The incidence of leukemic conversion from PNH is estimated to be less than 3% ... The patient was diagnosed with stage 3 aplastic anemia. She was administered immunosuppressive therapy (ie, ...
China has become the first country in the world to approve Roche’s anti-complement C5 antibody crovalimab, the only treatment for the rare disorder paroxysmal nocturnal haemoglobinuria (PNH ...
Roche's PiaSky has been approved by the European Commission, becoming the first therapy for rare blood disorder paroxysmal nocturnal haemoglobinuria (PNH) that can be given by monthly subcutaneous ...
Learn the lifestyle tips you can follow to care for your physical and mental health when you have paroxysmal nocturnal hemoglobinuria (PNH).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback